Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

italfarmaco s.p.a. - doxylamine, combinations - doxylamine, combinations

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bruno farmaceutici s.p.a. - bisoprolol, combinations - bisoprolol, combinations

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

Unione Europea - italiano - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

eg s.p.a. - brinzolamide, combinations - brinzolamide, combinations

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

doc generici srl - brinzolamide, combinations - brinzolamide, combinations

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

mylan s.p.a. - brinzolamide, combinations - brinzolamide, combinations

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

accord healthcare, s.l.u. - brinzolamide, combinations - brinzolamide, combinations

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

mylan s.p.a. - nitrofurantoin, combinations - nitrofurantoin, combinations